Skip to main content
Faes Farma S.A. logo

Faes Farma S.A. — Investor Relations & Filings

Ticker · FAE ISIN · ES0134950F36 LEI · 959800FXZQY7U3P1G969 MC Manufacturing
Filings indexed 193 across all filing types
Latest filing 2020-07-29 Interim / Quarterly Rep…
Country ES Spain
Listing MC FAE

About Faes Farma S.A.

https://faesfarma.com/en/

Faes Farma S.A. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products, healthcare solutions, and animal nutrition products. The company's pharmaceutical division develops treatments for conditions in therapeutic areas including allergy, gastroenterology, and immunology, with key proprietary molecules such as Bilastine, a leading antihistamine, and Calcifediol for Vitamin D deficiency. The animal nutrition business provides nutritional solutions and supplements for sustainable animal production. A core focus of the company is its investment in R&D to develop novel molecules and health solutions for its global markets.

Recent filings

Filing Released Lang Actions
Informe de negocio Junio 2020
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first half (January-June) of 2020 for Grupo Faes Farma. It contains detailed financial statements, including a 'Cuenta de Resultados' (Income Statement), balance sheet analysis, and a breakdown of business divisions (Farma, Nutrición, Bilastina, Internacional). It provides substantive financial data and management analysis of performance, fitting the definition of an Interim/Quarterly Report. H1 2020
2020-07-29 Spanish
Pago dividendo complementario
Notice of Dividend Amount Classification · 99% confidence The document explicitly announces the payment of a complementary dividend for the 2019 fiscal year, detailing the gross amount (€0.026 per share) and key dates (ExDate, Record Date, Payment Date). This content directly corresponds to the definition of a Notice of Dividend Amount.
2020-06-30 Spanish
Convocatoria Junta General de Accionistas 2020
AGM Information Classification · 99% confidence The document is explicitly titled "CONVOCATORIA DE LA JUNTA GENERAL DE ACCIONISTAS" (Notice of the General Shareholders' Meeting) and details the date, location, and the full 'ORDEN DEL DIA' (Agenda) for the meeting. The agenda includes items typical for an AGM, such as approval of annual accounts (2019), modification of bylaws, and a shareholder remuneration plan. This content directly relates to the formal proceedings and materials associated with an Annual General Meeting. Therefore, the appropriate classification is AGM-R.
2020-05-20 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is titled "MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS" (Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them). This form explicitly details transactions (Compra/Buy) in financial instruments (Acción/Share) conducted by a director (MARIANO UCAR ANGULO, PRESIDENTE). This directly corresponds to the definition of Director's Dealing, which covers reports of personal share transactions by company directors and executives (insider trades). The corresponding code is DIRS.
2020-05-07 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is titled "MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS" (Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them). This form explicitly details transactions (Compra/Buy) made by a Director (CONSEJERA) of the issuer (FAES FARMA, S.A.). This directly corresponds to the definition of Director's Dealing, which covers reports of personal share transactions by company directors and executives.
2020-04-01 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 99% confidence The document is titled "MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS" (Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them). This form explicitly details transactions (Compra/Buy) made by a Director ('CONSEJERO') of the issuer (FAES FARMA, S.A.). This type of filing, reporting personal share transactions by company directors and executives (insider trades), directly corresponds to the definition of Director's Dealing.
2020-03-28 Spanish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.